• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Long-term follow-up testing of red cell alloantibodies.

作者信息

Ramsey G, Smietana S J

机构信息

Department of Pathology, Northwestern University Medical School, Chicago, Illinois.

出版信息

Transfusion. 1994 Feb;34(2):122-4. doi: 10.1046/j.1537-2995.1994.34294143938.x.

DOI:10.1046/j.1537-2995.1994.34294143938.x
PMID:8310481
Abstract

BACKGROUND

In previous studies, 29 to 34 percent of potentially hemolytic red cell antibodies were not detected after short-term follow-up.

STUDY DESIGN AND METHODS

To examine long-term detection, records were reviewed for 44 consecutive patients who were tested more than 5 years after their potentially hemolytic red cell antibodies were first identified in this hospital.

RESULTS

After 5 to 10 years, 14 (39%) of 36 Rh, Kell, and Duffy system antibodies were not detected on at least one occasion. Twenty-two other such antibodies were sought again after more than 10 years; 10 (45%) were not detected. When restimulation by pregnancy was excluded, these rates were 42 and 48 percent, respectively.

CONCLUSION

Clinically significant red cell antibody formation is probably more common than previously realized, because nearly half of these antibodies are undetected after long-term follow-up.

摘要

相似文献

1
Long-term follow-up testing of red cell alloantibodies.
Transfusion. 1994 Feb;34(2):122-4. doi: 10.1046/j.1537-2995.1994.34294143938.x.
2
Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.除抗-D外筛查红细胞抗体以检测胎儿和新生儿溶血病的效果:荷兰的一项人群研究
Transfusion. 2008 May;48(5):941-52. doi: 10.1111/j.1537-2995.2007.01625.x. Epub 2008 Feb 1.
3
Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study.重型地中海贫血中的红细胞同种抗体。一项意大利合作研究的结果。
Transfusion. 1985 Mar-Apr;25(2):110-2. doi: 10.1046/j.1537-2995.1985.25285169198.x.
4
IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays.通过敏感血凝试验测定的抗Rh、抗Kell和抗Duffy抗体的IgG亚类分布。
Clin Exp Immunol. 1987 Mar;67(3):637-45.
5
Antibody screening & identification in the general patient population at a tertiary care hospital in New Delhi, India.印度新德里一家三级护理医院普通患者群体中的抗体筛查与鉴定
Indian J Med Res. 2014 Sep;140(3):401-5.
6
Evaluation of the optimal incubation temperature for detecting certain IgG antibodies with potential clinical significance.
Transfusion. 1988 May-Jun;28(3):210-3. doi: 10.1046/j.1537-2995.1988.28388219144.x.
7
Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.巴基斯坦定期输血的β地中海贫血患者中的红细胞同种免疫
Transfus Med. 2015 Apr;25(2):106-10. doi: 10.1111/tme.12196. Epub 2015 Apr 14.
8
Frequency and specificity of red cell antibodies in thalassemia patients in Albania.阿尔巴尼亚地中海贫血患者红细胞抗体的频率和特异性
Int J Lab Hematol. 2015 Aug;37(4):569-74. doi: 10.1111/ijlh.12362. Epub 2015 Apr 11.
9
Red cell antibodies in pregnancy: there is no 'critical titre'.孕期红细胞抗体:不存在“临界效价”。
Transfus Med. 1995 Sep;5(3):199-202. doi: 10.1111/j.1365-3148.1995.tb00228.x.
10
Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies.患有显著红细胞同种抗体的肝移植患者的不相容输血情况。
Transplant Proc. 1989 Jun;21(3):3531.

引用本文的文献

1
A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred.优化血液匹配策略的概念框架:平衡患者并发症与总费用
Front Med (Lausanne). 2018 Jul 25;5:199. doi: 10.3389/fmed.2018.00199. eCollection 2018.
2
The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders.临床和生物学因素对输血相关非 ABO 抗原同种免疫的影响:应答者、高应答者和无应答者。
Transfus Med Hemother. 2014 Nov;41(6):420-9. doi: 10.1159/000369109. Epub 2014 Nov 17.
3
Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.
D+血小板输注后抗-D 同种免疫的发生率较低:D 不相容血小板输注后抗-D 同种免疫(ADAPT)研究。
Br J Haematol. 2015 Feb;168(4):598-603. doi: 10.1111/bjh.13158. Epub 2014 Oct 4.
4
Minor RBC Ab and allo-SCT.轻微红细胞抗体与异基因造血干细胞移植
Bone Marrow Transplant. 2014 Mar;49(3):456-7. doi: 10.1038/bmt.2013.196. Epub 2013 Dec 9.
5
Comparison of different blood sample processing methods for sensitive detection of low level chimerism by RHD real-time PCR assay.通过RHD实时PCR检测法对不同血液样本处理方法进行比较以灵敏检测低水平嵌合体。
Chimerism. 2013 Jan-Mar;4(1):9-14. doi: 10.4161/chim.24248. Epub 2013 Jan 1.
6
The persistence of red cell alloantibodies.红细胞同种抗体的持续存在。
Blood Transfus. 2008 Oct;6(4):225-34. doi: 10.2450/2008.0021-08.